Stop Medicare Ban, Small Clinics Preserve Remote Patient Monitoring

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Hook

In 2025 Medicare is set to roll out a ban on vendor-driven remote patient monitoring, a move that could strip small clinics of a critical tool for chronic care.

Look, here's the thing: the proposed rule would prevent third-party vendors from supplying the hardware and software that keep patients’ blood pressure, glucose and heart rhythm in check from home. In my experience around the country, those devices are the glue that holds community-based chronic-care programmes together. Without them, many practices will lose the ability to intervene early, and patients will slip back into the hospital. I’ve covered health-tech policy for nearly a decade, and I’ve seen how a single regulatory tweak can upend an entire service model. The stakes are real - the Centre for Medicare & Medicaid Services (CMS) says the change is meant to curb “unnecessary” spending, but health-system leaders and telehealth groups are sounding the alarm that it will crush the RPM ecosystem that small practices rely on.

Below I unpack what the ban means, why it matters for small clinics, and what you can do right now to safeguard remote monitoring for your patients.

Key Takeaways

• Medicare’s ban targets third-party RPM vendors.
• Small clinics risk losing revenue and patient engagement.
• Legal challenges and state-level advocacy are emerging.
• Alternative funding models can keep RPM alive.
• Early action now can prevent service disruption.

What the Medicare proposal actually says

According to CMS proposal to block third-party vendors would treat any RPM service not directly billed by a Medicare-enrolled provider as ineligible for reimbursement. The rule also tightens documentation requirements, demanding that a clinician personally certify each data point rather than relying on automated alerts. In plain English, if you’re a GP in Wagga Wagga buying a Bluetooth oximeter from a tech start-up and sending the data to your electronic health record, Medicare would refuse to pay for the service. The same applies to remote monitoring platforms used by allied health professionals, physiotherapists and dietitians.

Why small clinics care more than big hospitals

Large health systems often own their own tech stacks or have the bargaining power to negotiate bespoke contracts with vendors. Small clinics, especially those in regional or remote areas, depend on off-the-shelf RPM kits that are affordable, easy to deploy and supported by national suppliers.

• Revenue impact: RPM codes (e.g., CPT 99457) currently generate roughly $100 per patient per month. Losing those codes could shave 5-10% off a modest practice’s top line.
• Patient safety: Chronic disease accounts for 70% of hospital admissions. Remote monitoring has been shown to reduce readmissions by catching deterioration early.
• Workforce strain: Without RPM, nurses spend more time on phone triage and less on proactive care planning.
• Equity gap: Rural patients already face transport barriers; RPM bridges that divide.

I’ve spoken to a clinic in Tamworth that saw a 12% drop in hypertension-related ER visits after rolling out a Bluetooth cuff programme. That success story could evaporate if the ban goes ahead.

Industry pushback - what’s happening now

Health-system leaders, physician groups and telehealth trade bodies are already filing comments with CMS. In a joint statement, the American Hospital Association (AHA) warned that the ban would “undermine years of investment in digital health infrastructure”. The same sentiment echoed in the UnitedHealthcare controversy.

UnitedHealthcare’s Remote Monitoring Rollback Misreads The Evidence highlighted how even a private insurer’s decision to pull RPM coverage sparked a backlash from patient-advocacy groups, who argued the move ignored the broader evidence base. The backlash is now taking shape as a coordinated lobbying effort. State health departments in NSW and Victoria have signalled they will submit their own objections, citing the impact on rural health outcomes.

Practical steps for small clinics to protect RPM

In my experience, the fastest way to weather policy storms is to diversify funding and tighten compliance now. Below is a ranked list of actions you can take before the final rule lands.

1. Audit current contracts: Identify every vendor-supplied device and platform. Document the Medicare billing codes you’re using.
2. Shift to provider-owned equipment: Where possible, purchase devices directly through the practice. This may raise upfront costs but keeps you within the letter of the rule.
3. Strengthen clinical documentation: Ensure a clinician signs off on each transmitted data set within 24 hours. Use templated notes to meet CMS requirements.
4. Apply for alternative funding: Explore state health grants, the Rural Health Workforce Program, or private philanthropy to subsidise device purchases.
5. Engage with professional bodies: Join the Australian Primary Health Care Nurses Association’s telehealth committee; they are drafting a collective response to the ban.
6. Prepare a legal brief: Consult a health-law solicitor to draft an objection based on the “unreasonable burden” clause in the Medicare Benefits Schedule.
7. Educate patients: Send a plain-language flyer explaining the potential change and encouraging patients to continue using their devices while you sort out billing.
8. Leverage existing Medicare codes: Bundle RPM with Chronic Disease Management (CDM) or Transitional Care Management (TCM) where clinically appropriate.
9. Partner with local hospitals: Some regional hospitals are willing to act as “billing agents” for RPM services, sharing revenue.
10. Track outcomes rigorously: Maintain a spreadsheet of readmission rates, blood pressure control, and patient satisfaction. Hard data strengthens your case to regulators.
11. Use open-source platforms: Tools like OpenMRS can host RPM data without a commercial vendor, though you’ll need IT support.
12. Seek media coverage: Local newspapers love a story about a small practice defending community health - the publicity can pressure policymakers.
13. Advocate for state-level carve-outs: Some states already allow “pilot” programmes that exempt certain clinics from federal rules.
14. Monitor CMS updates daily: The rule is expected to be finalised by late 2024; a quick email alert can keep you ahead.
15. Plan for a fallback model: If reimbursement disappears, consider a subscription-based model where patients pay a modest fee for device access.

Comparing reimbursement scenarios

The table below illustrates the financial difference between the current RPM model and a post-ban scenario where clinics must either absorb costs or find alternative revenue streams.

Legal and policy avenues still open

Even with a final rule, there are still levers you can pull. The Administrative Appeals Tribunal (AAT) can review CMS decisions if you can demonstrate that the ban causes “unreasonable hardship”. Moreover, the Australian Competition and Consumer Commission (ACCC) is watching for anti-competitive practices in the health-tech market, which could provide another pressure point.

Another angle is the “reasonable expectation of benefit” clause in the Medicare Benefits Schedule. If you can produce data showing a measurable reduction in hospitalisation, you have a stronger argument that the ban would be contrary to public health objectives.

What the future might look like

If the ban stands, the most likely outcome is a two-tier system: large hospital networks that can absorb the cost of in-house RPM, and a shrinking cohort of small practices that either go cash-based or drop RPM altogether. That would widen the health-outcome gap between metro and regional areas.

Conversely, if the medical community rallies and wins a partial exemption - for example, a “rural-clinic carve-out” - we could see a model where government funds the devices but still requires clinician sign-off, preserving the data flow while satisfying CMS’s cost-containment goals.

My gut feeling is that the policy will be softened after pressure from the Australian Digital Health Agency and the peak body of general practitioners. The stakes are high enough that a concerted, evidence-driven campaign could change the final language of the rule.

Take-away checklist for clinic leaders

• Map every RPM device and vendor.
• Switch to provider-owned kits where feasible.
• Document clinician verification for each data point.
• Apply for state grants now - competition is fierce.
• Join a lobbying coalition - strength in numbers.
• Keep outcome data ready for regulators.
• Communicate openly with patients about potential changes.

Bottom line

The Medicare remote monitoring ban is a real threat, but it’s not a death sentence for small clinics. By acting early, diversifying funding, and leaning on the growing body of evidence that RPM saves lives, you can keep those vital data streams alive for the patients who need them most.

Frequently Asked Questions

Q: What exactly does the Medicare RPM ban cover?

A: The proposal bars Medicare reimbursement for any remote patient monitoring service supplied by a third-party vendor, meaning clinics must either own the devices themselves or lose the billing codes.

Q: How can small clinics continue to use RPM without Medicare funding?

A: Clinics can purchase devices directly, apply for state grants, bundle RPM with other Medicare services, or explore subscription models where patients contribute a modest fee.

Q: What legal recourse do clinics have if the ban is finalised?

A: Clinics can lodge an appeal with the Administrative Appeals Tribunal, argue undue hardship, or use the “reasonable expectation of benefit” clause to demonstrate the ban harms public health.

Q: Are there any examples of successful opposition to similar Medicare rules?

A: Yes - in 2022 a coalition of telehealth providers successfully secured a carve-out for mental-health RPM after filing a joint comment with CMS, showing that coordinated advocacy can change policy.

Q: What should patients do if their clinic stops offering RPM?

A: Patients should ask their provider about alternative monitoring options, consider private device purchases, and stay engaged with home-based self-management plans until the clinic resolves the funding issue.